| 퓨쳐켐, 사업소개 | 2025-07-21T04:10:45.362381+00:00 |
| PSMA-PET 평가 방법과 RECIST가 ORR에 미치는 영향 | 2025-04-11T06:10:18.862980+00:00 |
| PSMA-PET 평가 방법과 RECIST가 ORR에 미치는 영향 | 2025-04-10T07:10:48.946604+00:00 |
| 퓨쳐켐 주주분들께 알리는 글 | 2024-12-06T05:10:55.586379+00:00 |
| 퓨쳐켐 주주분들께 알리는 글 | 2024-12-05T00:10:27.749685+00:00 |
| [퓨쳐켐] [nature research custom media] Investing in innovative approaches to oncology | 2023-03-28T05:10:59.913560+00:00 |
| 퓨쳐켐 주주 분들께 알리는 글 | 2023-02-27T01:10:30.536399+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-및-향후-전망 | 2022-10-21T07:43:04+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-및-향후-전망 | 2022-10-20T07:43:10+00:00 |
| 퓨쳐켐-투자자에게-드리는-말씀 | 2022-09-29T05:42:36+00:00 |
| 퓨쳐켐-투자자에게-드리는-말씀 | 2022-09-27T00:41:20+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-향후-전망-및-질의-응답 | 2022-08-26T07:42:41+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-향후-전망-및-질의-응답 | 2022-08-24T04:42:51+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-및-향후-전망 | 2022-05-16T00:42:48+00:00 |
| 퓨쳐켐-퓨쳐켐-주요사업설명-및-향후-전망 | 2021-11-29T07:42:19+00:00 |
| 퓨쳐켐-퓨쳐켐-3분기-실적-발표-누적-매출액-전년-29-상승 | 2021-11-15T04:42:39+00:00 |
| 퓨쳐켐-퓨쳐켐-전립선암-치료제-FC705-임상-1상-긍정적-중간결과-발표 | 2021-11-08T02:39:33+00:00 |
| 퓨쳐켐-퓨쳐켐-전립선암-진단의약품-FC303-미국-임상-1상-투여-완료 | 2021-11-05T01:42:20+00:00 |
| 퓨쳐켐-퓨쳐켐-전립선암-진단의약품-FC303-미국-임상-1상-투여-완료 | 2021-11-04T22:42:25+00:00 |
| 퓨쳐켐-퓨쳐켐-전립선암-치료제-FC705--FDA-Pre-IND-신청 | 2021-06-29T23:42:26+00:00 |